Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AVITA Medical, Inc.RCEL · Entity 5905 | Interim CFO | June 06, 2023 | June 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AVITA Medical, Inc.
Report date June 06, 2023 · Filed June 08, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.17 · Expires 2033-06-06 | Direct | 30,000 |
Reported balance
After 2023-06-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-06 · Grant · Acquired 30,000 · Balance 30,000 F1: These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2023 Filed Jun 8, 2023 20:35 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $14.17 | $0.00 |
DisclosureSEC source: 0001209191-23-035435 · doc4.xml · derivative · entry 1 Ekins Sean · CIK 0001833454 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-06-06 F1 · derivative.exercise_date: These Stock Options vest in three equal annual installments beginning on the date 12 months following the grant date. Read SEC document |
| March 17, 2021 Filed Mar 19, 2021 20:07 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantStock Options (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $21.93 | $0.00 |
DisclosureSEC source: 0001209191-21-022059 · doc4.xml · derivative · entry 1 Ekins Sean · CIK 0001833454 · Sr. VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-03-17 F1 · derivative.exercise_date: These Stock Options become exercisable in four equal annual installments beginning on March 17, 2022. Read SEC document |
| November 17, 2020 Filed Dec 16, 2020 21:03 UTC | AVITA Medical, Inc. RCEL · Entity 5905 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-063767 · doc4.xml · nonDerivative · entry 1 Ekins Sean · CIK 0001833454 · Sr. VP of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 F1 · price: Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. F2 · balance_after: Includes unvested Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.